发明名称 Antiviral therapy for hepatitis B using 2',3'-dideoxynucleosides.
摘要 <p>A method is disclosed for the treatment of hepadnavirus infection in animals. Animals infected with duck hepatitis B virus may be treated with the 2 min ,3 min -dideoxynucleoside of adenine, guanine, hypoxanthine, 2,6-diaminopurine or various analogs of substituted purines. Several purine 2 min ,3 min -dideoxynucleosides inhibit duck hepatitis B virus in hepatocyte culture &gt;99% at 1 mu g/ml. Potent in vivo efficacy of the 2,6-diaminopurine 2 min ,3 min -dideoxynucleoside for clearance of duck hepatitis B virus from the sera of Pekin ducks is demonstrated. The selective effect on hepadnavirus replication by the purine 2 min ,3 min -dideoxynucleosides is based on the discovery of an unexpected sensitivity of hepadnavirus to purine 2 min ,3 min -dideoxynucleoside analogs. These compounds present a new antiviral therapy of acute or persistent hepadnavirus infections.</p>
申请公布号 EP0302760(A2) 申请公布日期 1989.02.08
申请号 EP19880307307 申请日期 1988.08.08
申请人 THE GOVERNORS OF THE UNIVERSITY OF ALBERTA 发明人 TYRRELL, DAVID L.J.;ROBINS, MORRIS J.;SUZUKI, SATORU
分类号 C07D473/16;A61K;A61K31/52;A61K31/522;A61K31/70;A61P31/12;C07D473/18;C07D473/24;C07D473/30;C07D473/32;C07D473/34;C07D473/40 主分类号 C07D473/16
代理机构 代理人
主权项
地址